Skip to main content

Table 3 Cox regression hazards model for factors predicting all-cause mortality in 1264 newly diagnosed HIV infection

From: AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan

 

Univariable analysis

Multivariable analysisa

HR (95% CI)

P

AHR (95% CI)

P

Age, per 10-year increase

2.00 (1.71–2.32)

< 0.001

1.47 (1.21–1.77)

< 0.001

Male sex

1.09 (0.15–7.86)

0.93

3.67 (0.48–28.34)

0.21

HIV transmission route

 Homosexual

1.00 (Reference)

 

1.00 (Reference)

 

 Heterosexual

5.38 (3.03–9.55)

< 0.001

2.61 (1.32–5.16)

0.006

 Bisexual

2.67 (1.03–6.90)

0.043

1.86 (0.71–4.88)

0.21

 IDU

2.64 (0.36–19.38)

0.34

1.98 (0.26–14.98)

0.51

 Unknown

11.14 (2.65–46.78)

0.001

5.87 (1.27–27.08)

0.011

Period

 Period 1

1.00 (Reference)

   

 Period 2

1.32 (0.72–2.43)

0.37

1.48 (0.80–2.76)

0.21

 Period 3

0.71 (0.34–1.48)

0.35

0.92 (0.43–1.95)

0.82

Subgroup of CD4 cell count at presentation

17.59 (7.02–44.07)

< 0.001

  

 CD4 count ≥500 cells/μL

1.00 (Reference)

 

1.00 (Reference)

 

 CD4 count 200–499 cells/μL

1.29 (0.15–11.03)

0.82

1.21 (0.14–10.42)

0.86

 CD4 count < 200 cells/μL

16.86 (2.33–122.04)

0.005

11.03 (1.51–80.64)

0.018

HBsAg seropositivity

3.30 (1.80–6.05)

< 0.001

2.65 (1.42–4.94)

0.002

  1. Abbreviations: AHR adjusted hazard ratio, AOIs AIDS-defining opportunistic illnesses, CI confidence interval, HBsAg hepatitis B surface antigen, HCV hepatitis C virus, HR hazard ratio, IDU intravenous drug users
  2. aAll variables in the univariate analysis were selected for subsequent multivariate analysis